drugs
AstraZeneca’s CEO set for shock switch to Teva
July 13, 2017Medical Communications AstraZeneca, Teva, biotech, drugs, pascal soriot, pharma, pharmaceutical
It is no secret that Teva has been on the lookout for a new CEO and they had already been …
Ocular slapped with CRL despite last-ditch efforts
July 12, 2017Dextenza, Ocular Therapeutix, biotech, drugs, pharma, pharmaceutical
Ocular Therapeutix received a second CRL for its drug, Dextenza, despite submitting a last-minute application for an extension to its …
Enterome bolsters board with new executive appointment
July 12, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Enterome, biotech, drugs, healthcare, pharma, pharmaceuticals
Enterome, a clinical-stage company specialising in the personalised treatment of microbiome-related diseases based in Paris, France, has announced the appointment …
Nabriva Therapeutics recruit new COO
July 12, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nabriva Therapeutics, biotech, drugs, pharma, pharmaceutical
Nabriva Therapeutics, a pharmaceutical company that is developing new antibiotics for the treatment of serious infections, has brought Francesco Maria …
Teva accuses ex-employee of passing company secrets to boyfriend at rival generics firm
July 12, 2017Research and Development, Sales and Marketing Apotex, Teva, biotech, drugs, generics, healthcare, pharma, pharmaceuticals
Of all the controversy Teva has been embroiled in over the past years, the Israeli company now finds itself dogged …
Stada takeover back in motion after revised bid
July 12, 2017Research and Development Bain capital, Cinven, Stada, biotech, drugs, generics, pharma, pharmaceutical
Stada, the German generic manufacturer, has had a particularly protracted takeover journey to reach a point, now, where it looks …
Contaminated blood inquiry to probe thousands of deaths
July 12, 2017Medical Communications, Research and Development HCV, HIV, biotech, drugs, haemophilia, pharma, pharmaceutical
UK Government has announced that it will launch an inquiry to discover how 4,670 people were given blood infected by …
Investigational drug found to boost treatment efficacy in paediatric brain cancer
July 12, 2017Research and Development AT/RT, Cancer, DIPG, TAK228, biotech, drugs, pharma, pharmaceutical
Researchers from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University in Baltimore, US, have revealed in a report …
Flexion Therapeutics announce results for Zilretta trials in osteoarthritis pain
April 5, 2016Manufacturing and Production, Research and Development drugs, flexion, flexion therapeutics, osteoarthritis, pipeline, treatments, zilretta
Flexion Therapeutics has presented positive results from two pivotal clinical trials for its lead drug candidate, Zilretta, which show that …
Prescribing in England up 55% to £9bn over a decade
July 7, 2015Manufacturing and Production, Sales and Marketing NHS, NHSIC, drugs, health and social care information centre, net ingredient cost, prescribing
The number of drugs issued in England continues to soar, according to the latest NHS figures which show prescribing in …
Prices to be printed on all prescribed NHS drugs over £20
July 2, 2015Manufacturing and Production, Medical Communications, Sales and Marketing Jeremy Hunt, NHS, UK, drugs, health secretary, medicines
NHS drugs costing more than £20 will, from next year, have the price and the words “funded by the UK …
£15.8 million UK haul of fake drugs
June 19, 2015Manufacturing and Production, Sales and Marketing MHRA, counterfeit, drugs, fake, interpol
Counterfeit and unlicensed medicines and devices worth £15.8 million have been seized in the UK as part of a global …
Websites selling illegal drugs increasingly face closure
February 12, 2015Manufacturing and Production, Medical Communications, Sales and Marketing MHRA, counterfeit, drugs, illegal, on tap, websites
The number of websites shut down by the MHRA for selling illegal pharmaceutical products has increased dramatically in recent years, …
FDA approvals: 1996 versus 2014
January 12, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, John LaMattina, LaMattina, NDA, US, appovals, drugs
As highlighted in a number of recent stories, 2014 was a banner year for the biopharmaceutical industry with 41 new …
EMA ramps up adaptive pathways pilot
December 23, 2014Manufacturing and Production, Research and Development, Sales and Marketing EMA, adaptive pathways, drugs, regulator
Six medicines have been selected to move to the next stage of the EMA’s adaptive pathways pilot project, to explore …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
